发明授权
US06833140B2 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
有权
具有降低毒性的口服给药剂型GABA类似物前药
- 专利标题： Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
- 专利标题（中）： 具有降低毒性的口服给药剂型GABA类似物前药
-
申请号： US10170127申请日： 2002-06-11
-
公开(公告)号： US06833140B2公开(公告)日： 2004-12-21
- 发明人: Kenneth C. Cundy , Mark A. Gallop
- 申请人： Kenneth C. Cundy , Mark A. Gallop
- 主分类号： A61K920
- IPC分类号： A61K920
摘要：
The present invention provides an extended release oral dosage form of prodrugs of gabapentin and other GABA analogs, which dosage forms exhibit reduced toxicity. The dosage forms are particularly useful in administering those prodrugs of gabapentin and other GABA analogs that are metabolized to form an aldehyde. The dosage forms of the invention are useful for treating or preventing diseases and/or disorders for which the parent gabapentin or other GABA analog are known to be therapeutically effective.
公开/授权文献
信息查询
